Caitong International Asset Management’s Fortress Biotech FBIO Stock Holding History

Caitong International Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$594	Buy	+213	New	+$724	﹤0.01%	1584

Other funds holding FBIO

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Caitong International Asset Management's FBIO Position: Q1 2026 in Review

Caitong International Asset Management opened a new position in Fortress Biotech (FBIO) in Q1 2026: 213 shares worth $594. The stake represents ﹤0.01% of the portfolio and ranks #1584 among its holdings.

51 funds tracked by Wall St. Rank hold FBIO as of Q1 2026.

Caitong International Asset Management held 213 shares of Fortress Biotech worth $594 as of Q1 2026.
Fortress Biotech was a new Caitong International Asset Management position in Q1 2026.
Fortress Biotech made up ﹤0.01% of Caitong International Asset Management's portfolio in Q1 2026, its #1584 holding.
51 funds tracked by Wall St. Rank held Fortress Biotech as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.